# Maxcyte (MXCT) — Earnings

MXCT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mxct/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.08 |
| EPS estimate | −$0.09 |
| EPS surprise | +11.11% |
| Revenue surprise | +11.76% |
| Revenue | $7.3M |
| Revenue estimate | $6.5M |
| Reported | Aug 12, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1287098/000110465926095971/mxct-20260630x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 12, 2026 | −$0.09 | −$0.08 | 11.11% | $6.5M | $7.3M |
| Q1 2026 | May 12, 2026 | −$0.08 | −$0.04 | 47.23% | $7.3M | $9.7M |
| Q4 2025 | Mar 24, 2026 | −$0.08 | −$0.09 | -17.96% | $9.1M | $7.3M |
| Q3 2025 | Nov 5, 2025 | −$0.11 | −$0.12 | -7.24% | $6.8M | $6.8M |
| Q2 2025 | Aug 6, 2025 | −$0.10 | −$0.12 | -17.99% | $9.6M | $8.2M |
| Q1 2025 | May 7, 2025 | −$0.10 | −$0.10 | 2.44% | $9.2M | $10.4M |
| Q4 2024 | Mar 11, 2025 | −$0.12 | −$0.10 | 15.33% | $8.0M | $8.7M |
| Q3 2024 | Nov 6, 2024 | −$0.12 | −$0.11 | 8.33% | $7.5M | $8.2M |
| Q2 2024 | Aug 6, 2024 | −$0.12 | −$0.09 | 26.77% | $8.0M | $10.4M |
| Q1 2024 | May 7, 2024 | −$0.13 | −$0.09 | 28.40% | $7.5M | $11.3M |
| Q4 2023 | Mar 12, 2024 | −$0.07 | −$0.05 | 25.48% | $13.4M | $15.7M |
| Q3 2023 | Nov 8, 2023 | −$0.10 | −$0.11 | -9.02% | $8.9M | $8.0M |
| Q2 2023 | Aug 9, 2023 | −$0.10 | −$0.10 | -4.17% | $10.7M | $9.0M |
| Q1 2023 | May 10, 2023 | −$0.11 | −$0.11 | 1.79% | $8.3M | $8.6M |
| Q4 2022 | Mar 15, 2023 | −$0.08 | −$0.05 | 35.48% | $12.4M | $12.4M |
| Q3 2022 | Nov 9, 2022 | −$0.09 | −$0.06 | 33.33% | $10.4M | $10.6M |
| Q2 2022 | Aug 10, 2022 | −$0.08 | −$0.08 | -5.26% | $9.2M | $9.6M |
| Q1 2022 | May 9, 2022 | −$0.07 | −$0.04 | 39.39% | $8.5M | $11.6M |
| Q4 2021 | Mar 22, 2022 | −$0.06 | −$0.05 | 13.79% | $9.6M | $10.2M |
| Q3 2021 | Nov 10, 2021 | −$0.06 | −$0.03 | 47.83% | $7.3M | $10.1M |

## Frequently Asked Questions

### When did Maxcyte (MXCT) last report earnings?

Maxcyte last reported on Aug 12, 2026, covering fiscal Q2 2026.

### Did MXCT beat earnings estimates?

Yes. Maxcyte reported EPS of −$0.08 for Q2 2026 against a −$0.09 estimate — a 11.11% beat.

### How much revenue did MXCT report last quarter?

Maxcyte reported $7.3M in revenue for Q2 2026, against a consensus estimate of $6.5M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).